Moreover, it has also been reported that deficiency of dCK enhances resistance to acquired gemcitabine [31], and transfection with hCNT3 greatly increases gemcitabine uptake to overcome resistance in pancreatic cancer [32]. This evidence concerns the gene DCK and familial pancreatic carcinoma.